|
Market Closed -
Japan Exchange
06:30:00 18/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 6,960.00 JPY | -0.93% |
|
-0.61% | +28.22% |
Company Valuation: Kobayashi Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 704,427 | 650,295 | 503,841 | 463,131 | 403,511 | 517,397 | - | - |
| Change | - | -7.68% | -22.52% | -8.08% | -12.87% | 28.22% | - | - |
| Enterprise Value (EV) 1 | 596,011 | 546,554 | 424,992 | 398,232 | 333,575 | 457,619 | 447,936 | 439,821 |
| Change | - | -8.3% | -22.24% | -6.3% | -16.24% | 37.19% | -2.12% | -1.81% |
| P/E | 35.8x | 34.8x | 25.3x | 46x | 110x | 46.7x | 38.3x | 31x |
| PBR | 3.59x | 3.47x | 2.47x | 2.18x | 1.92x | 2.44x | 2.38x | 2.3x |
| PEG | - | 12.08x | 7.7x | -0.9x | -1.7x | 0x | 1.7x | 1.3x |
| Capitalization / Revenue | 4.54x | 3.91x | 2.9x | 2.8x | 2.43x | 3.03x | 2.88x | 2.77x |
| EV / Revenue | 3.84x | 3.29x | 2.45x | 2.4x | 2.01x | 2.68x | 2.5x | 2.35x |
| EV / EBITDA | 19.3x | 17.1x | 13.3x | 12.1x | 14.1x | 20.9x | 17x | 14.8x |
| EV / EBIT | 22.9x | 20.5x | 16.5x | 16x | 22.4x | 36.1x | 25.9x | 20.5x |
| EV / FCF | 31.8x | 31.1x | -350x | -29.2x | 68.5x | 39.7x | 30x | 25.7x |
| FCF Yield | 3.15% | 3.22% | -0.29% | -3.42% | 1.46% | 2.52% | 3.34% | 3.89% |
| Dividend per Share 2 | 83 | 90 | 101 | 102 | 104 | 106 | 110.8 | 114.3 |
| Rate of return | 0.92% | 1% | 1.49% | 1.64% | 1.92% | 1.52% | 1.59% | 1.64% |
| EPS 2 | 252.4 | 259.6 | 268.2 | 135.4 | 49.19 | 149 | 181.7 | 224.4 |
| Distribution rate | 32.9% | 34.7% | 37.7% | 75.3% | 211% | 71.2% | 60.9% | 50.9% |
| Net sales 1 | 155,252 | 166,258 | 173,455 | 165,600 | 165,742 | 170,818 | 179,450 | 186,870 |
| EBITDA 1 | 30,900 | 32,027 | 31,837 | 32,800 | 23,600 | 21,844 | 26,388 | 29,650 |
| EBIT 1 | 26,065 | 26,669 | 25,780 | 24,860 | 14,923 | 12,665 | 17,300 | 21,492 |
| Net income 1 | 19,715 | 20,022 | 20,338 | 10,067 | 3,656 | 11,050 | 13,688 | 16,548 |
| Net Debt 1 | -108,416 | -103,741 | -78,849 | -64,899 | -69,936 | -59,778 | -69,461 | -77,576 |
| Reference price 2 | 9,040.00 | 9,030.00 | 6,790.00 | 6,230.00 | 5,428.00 | 6,960.00 | 6,960.00 | 6,960.00 |
| Nbr of stocks (in thousands) | 77,923 | 72,015 | 74,203 | 74,339 | 74,339 | 74,339 | - | - |
| Announcement Date | 04/02/22 | 14/02/23 | 09/02/24 | 10/02/25 | 10/02/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 47.16x | 2.71x | 21.17x | 1.51% | 3.28B | ||
| 24.97x | 4.72x | 17.28x | 2.56% | 398B | ||
| 34.04x | 5.15x | 21.42x | 1.73% | 262B | ||
| 19.38x | 2.92x | 12.91x | 3.24% | 141B | ||
| 27.43x | 4.01x | 16.72x | 2.13% | 79.18B | ||
| 18.01x | 4.28x | 20.42x | 4.73% | 66.37B | ||
| 58.17x | 8.26x | 32.24x | 0.26% | 52.04B | ||
| 41.8x | 6.63x | 29.17x | 2.26% | 50.54B | ||
| 36.6x | 2.62x | 14.17x | 1.38% | 37.87B | ||
| 26.08x | 1.93x | 12.3x | 1.93% | 23.01B | ||
| Average | 33.36x | 4.32x | 19.78x | 2.17% | 111B | |
| Weighted average by Cap. | 28.95x | 4.63x | 18.89x | 2.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 4967 Stock
- Valuation Kobayashi Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















